Evidence map›Paper›PMID 32493812›Full record

ReviewJournal of immunology (Baltimore, Md. : 1950)2020

Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.

Judy Chen, William J Kelley, Daniel R Goldstein

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of immunology (Baltimore, Md. : 1950), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
1.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Classification and regulatory interactions of key transcription factors in COVID-19.Frontiers in cellular and infection microbiology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Judy ChenDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109.ORCID 0000-0002-5469-6619
William J KelleyDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109.ORCID 0000-0001-7447-6085
Daniel R GoldsteinDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI 48109; drgoldst@umich.edu.ORCID 0000-0001-6695-979X
University of Michigan · US

Funding

RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
Training Program in Molecular HematologyT32HL007622 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SUNG WON CHOI, Jordan A. Shavit · 1986 to 2026
$9.2M
Mechanisms to augment primary immunity in agingR01AG028082 · NIA · YALE UNIVERSITY · PI DENG, JANE C · 2007 to 2023
$6.9M
Physician Scientist Training in Age-Related DiseasesT32AG062403 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MIN, LILLIAN CHIANG, MODY, LONA · 2020 to 2025
$2.7M
Novel mechanisms of age-enhanced vasculopathy after heart transplantationR01AI138347 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GOLDSTEIN, DANIEL ROBERT · 2018 to 2022
$2.7M
Novel Inflammatory Pathway of Aged-Enhanced AtherosclerosisR01HL127687 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GOLDSTEIN, DANIEL ROBERT · 2016 to 2019
$1.6M
Academic leadership in the Biology of Aging and Cardiovascular DiseasesK07AG050096 · NIA · YALE UNIVERSITY · PI GOLDSTEIN, DANIEL ROBERT · 2015 to 2019
$651k
NHLBI NIH HHS R01 HL127687NHLBI NIH HHS T32 HL007622NIAID NIH HHS R01 AI138347NIAID NIH HHS T32 AI007413NIA NIH HHS K07 AG050096NIA NIH HHS R01 AG028082NIA NIH HHS T32 AG062403
6 · The paper itself

Abstract

Aging impairs immunity to promote diseases, especially respiratory viral infections. The current COVID-19 pandemic, resulting from SARS-CoV-2, induces acute pneumonia, a phenotype that is alarmingly increased with aging. In this article, we review findings of how aging alters immunity to respiratory viral infections to identify age-impacted pathways common to several viral pathogens, permitting us to speculate about potential mechanisms of age-enhanced mortality to COVID-19. Aging generally leads to exaggerated innate immunity, particularly in the form of elevated neutrophil accumulation across murine and large animal studies of influenza infection. COVID-19 patients who succumb exhibit a 2-fold increase in neutrophilia, suggesting that exaggerated innate immunity contributes to age-enhanced mortality to SARS-CoV-2 infection. Further investigation in relevant experimental models will elucidate the mechanisms by which aging impacts respiratory viral infections, including SARS-CoV-2. Such investigation could identify therapies to reduce the suffering of the population at large, but especially among older people, infected with respiratory viruses.

Indexed as

AgingBetacoronavirusCardiovascular DiseasesCoronavirus InfectionsCOVID-19CytokinesHumansInfluenza, HumanPandemicsPneumonia, ViralRespiratory Tract InfectionsSARS-CoV-2Severe acute respiratory syndrome-related coronavirusCytokines

Identifiers

PMID32493812
PMCPMC7343582
OpenAlexW3030381168

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.